cilostazol has been researched along with Graft Occlusion, Vascular in 13 studies
Graft Occlusion, Vascular: Obstruction of flow in biological or prosthetic vascular grafts.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cilostazol improves walking distance in patients with intermittent claudication and reduces restenosis after coronary intervention, but its efficacy remains unclear after EVT for femoropopliteal disease." | 9.14 | Efficacy of cilostazol after endovascular therapy for femoropopliteal artery disease in patients with intermittent claudication. ( Hikichi, Y; Kawasaki, T; Nakashima, H; Nobuyoshi, M; Soga, Y; Tsurugida, M; Yokoi, H, 2009) |
| "Cilostazol-treated grafts had a thinner intima layer with less myocyte content compared with control grafts, amounting to an 82 percent decrease in total intima area compared with controls." | 5.40 | Topical cilostazol inhibits neointimal hyperplasia in a rat interposition vein graft model. ( Akelina, Y; Ascherman, JA; Malliaris, SD; Munabi, NCO, 2014) |
| "Cilostazol improves walking distance in patients with intermittent claudication and reduces restenosis after coronary intervention, but its efficacy remains unclear after EVT for femoropopliteal disease." | 5.14 | Efficacy of cilostazol after endovascular therapy for femoropopliteal artery disease in patients with intermittent claudication. ( Hikichi, Y; Kawasaki, T; Nakashima, H; Nobuyoshi, M; Soga, Y; Tsurugida, M; Yokoi, H, 2009) |
| "Cilostazol-treated grafts had a thinner intima layer with less myocyte content compared with control grafts, amounting to an 82 percent decrease in total intima area compared with controls." | 1.40 | Topical cilostazol inhibits neointimal hyperplasia in a rat interposition vein graft model. ( Akelina, Y; Ascherman, JA; Malliaris, SD; Munabi, NCO, 2014) |
| "Cilostazol is a unique antiplatelet drug that has vasodilatory effects and inhibits smooth muscle cell proliferation." | 1.33 | Cilostazol reduces target lesion revascularization after percutaneous transluminal angioplasty in the femoropopliteal artery. ( Awata, M; Iida, O; Ito, N; Kitakaze, M; Kotani, J; Minamiguchi, H; Morozumi, T; Nagata, S; Nanto, S; Onishi, T; Oshima, F; Uematsu, M, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Warner, CJ | 1 |
| Greaves, SW | 1 |
| Larson, RJ | 1 |
| Stone, DH | 1 |
| Powell, RJ | 1 |
| Walsh, DB | 1 |
| Goodney, PP | 1 |
| Malliaris, SD | 1 |
| Munabi, NCO | 1 |
| Akelina, Y | 1 |
| Ascherman, JA | 1 |
| Tara, S | 1 |
| Kurobe, H | 1 |
| de Dios Ruiz Rosado, J | 1 |
| Best, CA | 1 |
| Shoji, T | 1 |
| Mahler, N | 1 |
| Yi, T | 1 |
| Lee, YU | 1 |
| Sugiura, T | 1 |
| Hibino, N | 1 |
| Partida-Sanchez, S | 1 |
| Breuer, CK | 1 |
| Shinoka, T | 1 |
| Soga, Y | 2 |
| Yokoi, H | 2 |
| Kawasaki, T | 1 |
| Nakashima, H | 1 |
| Tsurugida, M | 1 |
| Hikichi, Y | 1 |
| Nobuyoshi, M | 2 |
| Lee, SW | 2 |
| Chun, KJ | 1 |
| Park, SW | 1 |
| Kim, HS | 1 |
| Kim, YH | 1 |
| Yun, SC | 1 |
| Kim, WJ | 2 |
| Lee, JY | 2 |
| Park, DW | 1 |
| Lee, CW | 1 |
| Hong, MK | 1 |
| Rhee, KS | 1 |
| Chae, JK | 1 |
| Ko, JK | 1 |
| Park, JH | 1 |
| Lee, JH | 1 |
| Choi, SW | 1 |
| Jeong, JO | 1 |
| Seong, IW | 1 |
| Jon, S | 1 |
| Cho, YH | 1 |
| Lee, NH | 1 |
| Kim, JH | 1 |
| Park, SJ | 1 |
| Yamagami, H | 1 |
| Sakai, N | 1 |
| Matsumaru, Y | 1 |
| Sakai, C | 1 |
| Kai, Y | 1 |
| Sugiu, K | 1 |
| Fujinaka, T | 1 |
| Matsumoto, Y | 1 |
| Miyachi, S | 1 |
| Yoshimura, S | 1 |
| Hyogo, T | 1 |
| Kuwayama, N | 1 |
| Hyodo, A | 1 |
| Suzuki, K | 1 |
| Iida, O | 2 |
| Hirano, K | 1 |
| Inoue, N | 1 |
| Uematsu, M | 2 |
| Muramatsu, T | 1 |
| Nanto, S | 2 |
| Meguro, T | 1 |
| Nakamura, M | 1 |
| Takayama, K | 1 |
| Taoka, T | 1 |
| Nakagawa, H | 1 |
| Myouchin, K | 1 |
| Wada, T | 1 |
| Sakamoto, M | 1 |
| Furuichi, K | 1 |
| Iwasaki, S | 1 |
| Kurokawa, S | 1 |
| Kichikawa, K | 1 |
| Jang, JS | 1 |
| Jin, HY | 1 |
| Seo, JS | 1 |
| Yang, TH | 1 |
| Kim, DK | 2 |
| Kim, DS | 1 |
| Seol, SH | 1 |
| Kim, DI | 1 |
| Cho, KI | 1 |
| Kim, BH | 1 |
| Park, YH | 1 |
| Je, HG | 1 |
| Jeong, YH | 1 |
| Takeyasu, N | 1 |
| Watanabe, S | 1 |
| Noguchi, Y | 1 |
| Ishikawa, K | 1 |
| Fumikura, Y | 1 |
| Yamaguchi, I | 1 |
| Morozumi, T | 1 |
| Kotani, J | 1 |
| Awata, M | 1 |
| Onishi, T | 1 |
| Ito, N | 1 |
| Oshima, F | 1 |
| Minamiguchi, H | 1 |
| Kitakaze, M | 1 |
| Nagata, S | 1 |
| Yoon, Y | 1 |
| Shim, WH | 1 |
| Lee, DH | 1 |
| Pyun, WB | 1 |
| Kim, IJ | 1 |
| Jang, Y | 1 |
| Cho, SY | 1 |
2 reviews available for cilostazol and Graft Occlusion, Vascular
| Article | Year |
|---|---|
Cilostazol is associated with improved outcomes after peripheral endovascular interventions.
Topics: Arterial Occlusive Diseases; Cilostazol; Endovascular Procedures; Femoral Artery; Global Health; Gra | 2014 |
A meta-analysis of randomized controlled trials appraising the efficacy and safety of cilostazol after coronary artery stent implantation.
Topics: Aspirin; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Cilostazol; Clopidogrel; Com | 2012 |
5 trials available for cilostazol and Graft Occlusion, Vascular
| Article | Year |
|---|---|
Efficacy of cilostazol after endovascular therapy for femoropopliteal artery disease in patients with intermittent claudication.
Topics: Aged; Angioplasty, Balloon; Cilostazol; Female; Femoral Artery; Graft Occlusion, Vascular; Humans; I | 2009 |
Comparison of Triple antiplatelet therapy and dual antiplatelet therapy in patients at high risk of restenosis after drug-eluting stent implantation (from the DECLARE-DIABETES and -LONG Trials).
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Clopidogrel; Coronary Restenosis; Diabete | 2010 |
Long-term results of the S.M.A.R.T. Control(TM) stent for superficial femoral artery lesions, J-SMART registry.
Topics: Age Factors; Aged; Aged, 80 and over; Cilostazol; Female; Femoral Artery; Follow-Up Studies; Graft O | 2011 |
Randomized comparison of cilostazol vs ticlopidine for antiplatelet therapy after coronary stenting.
Topics: Aged; Cilostazol; Coronary Disease; Double-Blind Method; Female; Graft Occlusion, Vascular; Humans; | 2005 |
Usefulness of cilostazol versus ticlopidine in coronary artery stenting.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Aspirin; Cause of Death; Cilostazol; Coronary Angiograp | 1999 |
6 other studies available for cilostazol and Graft Occlusion, Vascular
| Article | Year |
|---|---|
Topical cilostazol inhibits neointimal hyperplasia in a rat interposition vein graft model.
Topics: Administration, Topical; Animals; Cilostazol; Graft Occlusion, Vascular; Hyperplasia; Neointima; Pla | 2014 |
Cilostazol, Not Aspirin, Prevents Stenosis of Bioresorbable Vascular Grafts in a Venous Model.
Topics: Absorbable Implants; Animals; Aspirin; Blood Vessel Prosthesis; Cell Proliferation; Cilostazol; Dise | 2015 |
Periprocedural cilostazol treatment and restenosis after carotid artery stenting: the Retrospective Study of In-Stent Restenosis after Carotid Artery Stenting (ReSISteR-CAS).
Topics: Aged; Carotid Stenosis; Cilostazol; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Pl | 2012 |
The door is open and the next step is forthcoming--lesson from J-SMART registry.
Topics: Age Factors; Aged; Aged, 80 and over; Cilostazol; Female; Femoral Artery; Follow-Up Studies; Graft O | 2011 |
Effect of cilostazol in preventing restenosis after carotid artery stenting using the carotid wallstent: a multicenter retrospective study.
Topics: Aged; Aged, 80 and over; Carotid Artery Diseases; Cilostazol; Female; Graft Occlusion, Vascular; Hum | 2012 |
Cilostazol reduces target lesion revascularization after percutaneous transluminal angioplasty in the femoropopliteal artery.
Topics: Aged; Angioplasty, Balloon; Cell Proliferation; Cilostazol; Female; Femoral Artery; Graft Occlusion, | 2005 |